Piramal Pharma Ends At Rs 192 On Debut, Valued At Rs 22,882 Cr At Close

Domestic brokerage Motilal Oswal has set a price target of Rs 210 for the stock

Topics

Piramal | Piramal Enterprises | Stock Market

BS Reporter  |  Mumbai 



Piramal Pharma

Photo: Twitter

').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();

Shares of Pharma closed at Rs 192 on Wednesday during their listing debut.

The company, which got listed separately following its demerger from Enterprises, was valued at Rs 22,882 crore at last close.

In FY22, the contract development and manufacturing (CDMO) vertical accounted for 59 per cent of its sales, complex hospital generics (CHG), 30 per cent and India consumer products business, 11 per cent.

Domestic brokerage has set a price target of Rs 210 for the stock.

“Using sum of the parts (SOTP), we value the CDMO business, CHG, and the ICH business based on 16x, 12x, and 18x FY24E EV/EBITDA respectively. We value Allergan JV (49 per cent stake) based on 18x FY24E PE,” it says.


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

First Published: Wed, October 19 2022. 18:09 IST


RECENT NEWS

Coutts Sets Scope On New Continent

Coutts steps into private marketsCoutts, the private bank best known for serving Britain’s wealthiest families and the... Read more

From Cypherpunk To Citadel

How Crypto Moved from the Wild West to the Mainstream Financial SystemA long-form analysis of Bitcoin's journey from fri... Read more

ACB Securities: Building Scale, Trust & Innovation

ACB Securities: Building Scale, Trust and Innovation in Vietnam’s Capital MarketsACB Securities (ACBS) is emerging as ... Read more

War Risk Returns To Markets As VIX Surges

For most of the past year, global markets behaved as though geopolitical risk had largely disappeared. Inflation was eas... Read more

Stablecoin The Future Of Currency?

The payments system is undergoing a quiet but consequential shift. What was once the exclusive preserve of central banks... Read more

BoE Loosens Capital Rules

The Bank of England has taken a significant step towards easing post-crisis regulation by lowering its estimate of the c... Read more